Rep. James Comer (R-KY) (Graeme Sloan/Sipa USA/Sipa via AP Images)

House over­sight chair calls for in­ves­ti­ga­tion in­to PBM­s' tac­tics to in­crease drug costs

In an­oth­er ef­fort to in­ves­ti­gate phar­ma mid­dle­men and their im­pact on health­care costs, House Over­sight Com­mit­tee Chair James Com­er (R-KY) is launch­ing an in­ves­ti­ga­tion in­to phar­ma­cy ben­e­fit man­agers’ (PBM) “tac­tics that are harm­ing pa­tient care and in­creas­ing costs for con­sumers.”

He’s one of sev­er­al politi­cians who have called for greater trans­paren­cy in­to PBMs, the mid­dle­men who ne­go­ti­ate re­bates with drug­mak­ers in ex­change for for­mu­la­ry cov­er­age.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.